Clinical Trial Update: Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered

View source ↗

Summary

Clinical trial update describing complete endosonographic intrathoracic nodal staging for NSCLC patients considered for SABR; current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Non Small Cell Lung Cancer (NSCLC), Intrathoracic Nodal Staging | Status: UNKNOWN